Clinical Utility and Gait Analysis of NextAR System AUS

Launched by MEDACTA INTERNATIONAL SA · May 8, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new system called NextAR, which aims to improve the way knee implants are positioned during total knee replacement surgery. The goal is to see if using personalized data from the NextAR system can help balance the soft tissues around the knee better, leading to outcomes that feel more natural for patients. This study is currently looking for participants aged 18 and older who have severe arthritis in their knees and are planning to undergo knee replacement surgery.

If you decide to take part in this trial, you will be randomly assigned to either receive the standard care or the NextAR system's guidance during your surgery. This means you may or may not receive the new technology, but either way, you will receive excellent medical care. Participants should be aware that certain health conditions, previous knee surgeries, or being significantly overweight may prevent them from joining the study. Overall, this trial could provide valuable insights into how advanced technology can enhance knee surgery results.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • End-stage osteoarthritis of the knee suitable for total knee arthroplasty.
• • Aged over 18 years.
• Exclusion Criteria:
• • Unsuitable for TKR due to chronic infection, medical disease, inability to consent, inability to attend for post-operative follow-up, significant psychiatric issues, substance abuse issues
• • Previous reconstructive/fracture/arthroplasty surgery on affected knee
• • Active inflammation arthropathy
• • Significant extra articular deformity
• • Morbidly Obese (BMI \>40)
• • Pregnant women